viloxazine has been researched along with Depressive Disorder in 38 studies
Viloxazine: A morpholine derivative used as an antidepressant. It is similar in action to IMIPRAMINE.
Depressive Disorder: An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " for 10 days) on the steady-state plasma concentrations of Oxcarbazepine (OXC), its active metabolite 10, 11-dihydro-10-hydroxy-carbazepine (MHD) and the corresponding diol (DHD) were studied in a randomized, double-blind cross-over placebo-controlled trial in 6 epileptic patients stabilized on a fixed dosage of OXC." | 6.67 | Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy. ( Artesi, C; Di Perri, R; Fazio, A; Oteri, G; Perucca, E; Pisani, F; Xiao, B, 1994) |
| "Depressive disorders are frequently associated with alcohol abuse." | 6.67 | Alcoholism and depression: a placebo controlled study with viloxazine. ( Altamura, AC; Girardi, T; Mauri, MC; Panetta, B, 1990) |
| "Six cases of convulsive seizures occurring during treatment with viloxazine notified to the Committee on Safety of Medicines (CSM) and two other cases from Japan were reviewed." | 3.67 | Does viloxazine have epileptogenic properties? ( Edwards, JG; Glen-Bott, M, 1984) |
| " for 10 days) on the steady-state plasma concentrations of Oxcarbazepine (OXC), its active metabolite 10, 11-dihydro-10-hydroxy-carbazepine (MHD) and the corresponding diol (DHD) were studied in a randomized, double-blind cross-over placebo-controlled trial in 6 epileptic patients stabilized on a fixed dosage of OXC." | 2.67 | Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy. ( Artesi, C; Di Perri, R; Fazio, A; Oteri, G; Perucca, E; Pisani, F; Xiao, B, 1994) |
| "Depressive disorders are frequently associated with alcohol abuse." | 2.67 | Alcoholism and depression: a placebo controlled study with viloxazine. ( Altamura, AC; Girardi, T; Mauri, MC; Panetta, B, 1990) |
| "Viloxazine was generally well tolerated and side-effects, when they occurred, were generally a mild upper gastro-intestinal disturbance." | 2.64 | A placebo controlled trial of viloxazine with and without tranquillizers in depressive illness. ( Magnus, RV, 1975) |
| "Viloxazine was effective in different depressive situations, regardless of the age of the patient or the therapeutic context, even if in Group 2 the out-patients did significantly better (p less than 0." | 1.27 | Age, therapeutic "milieu" and clinical outcome in depressive patients treated with viloxazine: a study with plasma levels. ( Altamura, AC; Guercetti, G; Mauri, MC, 1986) |
| " The first, of mild severity, was controlled with an increase in daily dosage of 100 mg." | 1.26 | [Long-term tolerance of viloxazine]. ( Brion, S; Chevalier, JF, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (76.32) | 18.7374 |
| 1990's | 8 (21.05) | 18.2507 |
| 2000's | 1 (2.63) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rüther, E | 1 |
| Norman, TR | 1 |
| Burrows, GD | 1 |
| Davies, BM | 1 |
| Maguire, KP | 1 |
| Wurm, JM | 1 |
| Edwards, JG | 2 |
| Glen-Bott, M | 1 |
| Falcy, M | 1 |
| Riboulet-Delmas, G | 1 |
| Efthymiou, ML | 1 |
| Kabes, J | 3 |
| Dostal, T | 3 |
| Balon, R | 2 |
| Papezová, H | 1 |
| McEvoy, JP | 4 |
| Sheridan, WF | 1 |
| Stewart, WR | 1 |
| Ban, TA | 5 |
| Wilson, WH | 5 |
| Guy, W | 5 |
| Schaffer, JD | 2 |
| Petrie, WM | 3 |
| Náhunek, K | 1 |
| Svestka, J | 1 |
| Molcan, J | 1 |
| Caplová, T | 1 |
| Hynek, K | 1 |
| Faltus, F | 1 |
| Holland, RP | 1 |
| Libiger, J | 1 |
| Berney, S | 1 |
| Sebjanic, V | 1 |
| Grombein, S | 1 |
| Maistrello, I | 1 |
| Grassi, G | 1 |
| Bertolino, A | 1 |
| Valerio, P | 1 |
| Pistollato, G | 1 |
| Soverini, S | 1 |
| Thompson, PJ | 1 |
| Trimble, MR | 1 |
| Brion, S | 1 |
| Chevalier, JF | 1 |
| Jamieson, RC | 1 |
| Vandel, B | 1 |
| Vandel, S | 1 |
| Allers, G | 1 |
| Volmat, R | 1 |
| Ivanov, V | 1 |
| Popov, G | 1 |
| Amin, M | 1 |
| Khan, P | 1 |
| Lehmann, HE | 1 |
| Pisani, F | 3 |
| Fazio, A | 3 |
| Oteri, G | 3 |
| Artesi, C | 2 |
| Xiao, B | 1 |
| Perucca, E | 3 |
| Di Perri, R | 3 |
| Fritze, J | 1 |
| Lanczik, M | 1 |
| Sofic, E | 1 |
| Struck, M | 1 |
| Riederer, P | 1 |
| León, CA | 1 |
| Vigoya, J | 1 |
| Conde, S | 1 |
| Campo, G | 1 |
| Castrillón, E | 1 |
| León, A | 1 |
| Lestra, C | 1 |
| d'Amato, T | 1 |
| Ghaemmaghami, C | 1 |
| Perret-Liaudet, A | 1 |
| Broyer, M | 1 |
| Renaud, B | 1 |
| Dalery, J | 1 |
| Chamba, G | 1 |
| Leroi, AM | 1 |
| Lalaude, O | 1 |
| Antonietti, M | 1 |
| Touchais, JY | 1 |
| Ducrotte, P | 1 |
| Menard, JF | 1 |
| Denis, P | 1 |
| Sedman, G | 1 |
| Magnus, RV | 1 |
| Loeb, C | 1 |
| Roccatagliatà, G | 1 |
| Besio, G | 1 |
| Russo, M | 2 |
| Trio, R | 2 |
| Langs, T | 1 |
| Thomas, F | 1 |
| Jupas, JJ | 1 |
| Ravaud, Y | 1 |
| Altamura, AC | 2 |
| Mauri, MC | 2 |
| Girardi, T | 1 |
| Panetta, B | 1 |
| De Leo, D | 1 |
| Magni, G | 1 |
| Guercetti, G | 1 |
| Guliamov, MG | 1 |
| Pisani, B | 1 |
| Haehn, KD | 1 |
| Tosca, P | 1 |
| Zerbi, F | 1 |
| Romani, A | 1 |
| Molini, G | 1 |
| Cairoli, S | 1 |
| Montagna, M | 1 |
| Gabba, A | 1 |
| Groppi, A | 1 |
1 review available for viloxazine and Depressive Disorder
| Article | Year |
|---|---|
Update of antidepressants: lofepramine, amoxapine and viloxazine.
Topics: Amoxapine; Depressive Disorder; Humans; Lofepramine; Viloxazine | 1990 |
15 trials available for viloxazine and Depressive Disorder
| Article | Year |
|---|---|
[The antidepressant viloxazin. A multicenter study under practice conditions].
Topics: Adjustment Disorders; Adolescent; Adult; Aged; Antipsychotic Agents; Clinical Trials as Topic; Depre | 1982 |
Viloxazine in the treatment of depressive neurosis: a controlled clinical study with doxepin and placebo.
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Doxepin; Female; Humans; | 1980 |
Viloxazine in the treatment of depressive neurosis: a placebo and standard (imipramine) controlled clinical study.
Topics: Adult; Anxiety; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; | 1980 |
Multicentre study with viloxazine (Vivalan) in depressed patients.
Topics: Adult; Aged; Bipolar Disorder; Clinical Trials as Topic; Depressive Disorder; Depressive Disorder, M | 1980 |
Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramin | 1982 |
A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressives.
Topics: Adolescent; Adult; Amitriptyline; Clinical Trials as Topic; Depressive Disorder; Dizziness; Doxepin; | 1982 |
Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.
Topics: Adolescent; Adult; Aged; Body Weight; Clinical Trials as Topic; Depressive Disorder; Female; Hemodyn | 1982 |
Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Cross-Over Studies; Depressive Disorder; Double-Blind Method; | 1994 |
Cholinergic neurotransmission seems not to be involved in depression but possibly in personality.
Topics: Acetylcholine; Adolescent; Adult; Aged; Arousal; Biperiden; Cholinergic Fibers; Depressive Disorder; | 1995 |
[Comparison of the effect of amisulpride and viloxazine in the treatment of dysthymia].
Topics: Adolescent; Adult; Age Distribution; Amisulpride; Depressive Disorder; Double-Blind Method; Female; | 1994 |
Double-blind trial of sustained-release amitriptyline compared with viloxazine in moderate to severe depressive illness.
Topics: Adult; Aged; Amitriptyline; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; F | 1977 |
Viloxazine: an assessment of its potential rapid antidepressant action and unwanted effects.
Topics: Adolescent; Adult; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mental Status Sch | 1977 |
A placebo controlled trial of viloxazine with and without tranquillizers in depressive illness.
Topics: Depressive Disorder; Diazepam; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; | 1975 |
Alcoholism and depression: a placebo controlled study with viloxazine.
Topics: Adult; Alcohol Drinking; Alcoholism; Depressive Disorder; Double-Blind Method; Female; Humans; Male; | 1990 |
Does viloxazine really improve sex drive? A double-blind controlled study.
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Humans; Libido; Male; Mid | 1986 |
22 other studies available for viloxazine and Depressive Disorder
| Article | Year |
|---|---|
Viloxazine plasma concentrations and clinical response.
Topics: Administration, Oral; Adult; Depressive Disorder; Female; Humans; Hypotension; Male; Middle Aged; Mo | 1980 |
Does viloxazine have epileptogenic properties?
Topics: Adult; Depressive Disorder; Drug Therapy, Combination; Epilepsy, Tonic-Clonic; Female; Humans; Male; | 1984 |
[Acute poisoning by viloxazine chlorhydrate taken by itself].
Topics: Adolescent; Adult; Aged; Child; Depressive Disorder; Dose-Response Relationship, Drug; Female; Franc | 1983 |
[A profile of the clinical effectiveness of second generation antidepressive agents].
Topics: Adult; Anthracenes; Depressive Disorder; Female; Humans; Isoquinolines; Male; Maprotiline; Middle Ag | 1984 |
Recognition of adverse drug reactions in depressed patients treated with viloxazine (Vicilan).
Topics: Adult; Depressive Disorder; Female; Humans; Male; Morpholines; Psychiatric Status Rating Scales; Vil | 1982 |
Non-MAOI antidepressant drugs and cognitive functions: a review.
Topics: Amitriptyline; Antidepressive Agents; Cognition; Cognition Disorders; Depressive Disorder; Dose-Resp | 1982 |
[Long-term tolerance of viloxazine].
Topics: Adult; Aged; Depressive Disorder; Electrocardiography; Electroencephalography; Female; Humans; Liver | 1982 |
Viloxazine in the treatment of endogenous depression. A standard (amitriptyline) controlled clinical study.
Topics: Adolescent; Adult; Amitriptyline; Bipolar Disorder; Depressive Disorder; Depressive Disorder, Major; | 1982 |
Clinical pharmacology of viloxazine hydrochloride.
Topics: Depressive Disorder; Electroencephalography; Female; Humans; Male; Middle Aged; Morpholines; Motor S | 1981 |
[Comparative results of the treatment of anxiety in the depressive syndrome with Tolvon, Vivalan and Alival].
Topics: Aged; Anxiety Disorders; Depressive Disorder; Dibenzazepines; Humans; Isoquinolines; Mianserin; Midd | 1981 |
Do have antidepressants of the second generation anxiolytic properties?
Topics: Adult; Anthracenes; Anxiety; Depressive Disorder; Humans; Isoquinolines; Maprotiline; Middle Aged; M | 1981 |
A comparative study of salivation in affective disorders.
Topics: Adult; Depressive Disorder; Female; Humans; Imipramine; Male; Middle Aged; Salivation; Viloxazine | 1980 |
Biological parameters in major depression: effects of paroxetine, viloxazine, moclobemide, and electroconvulsive therapy. Relation to early clinical outcome.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents; Benzamides; Biomarkers; Biopterins | 1998 |
Prolonged stationary colonic motility recording in seven patients with severe constipation secondary to antidepressants.
Topics: Adult; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Cathartics; Cholinergic Antagonists; | 2000 |
[Variations in the urinary level of MHPG in depressive syndromes].
Topics: Adult; Age Factors; Aged; Antidepressive Agents, Tricyclic; Anxiety; Depression; Depressive Disorder | 1979 |
Elevation of plasma phenytoin by viloxazine in epileptic patients: a clinically significant drug interaction.
Topics: Adult; Aged; Depressive Disorder; Drug Interactions; Epilepsy; Female; Humans; Male; Middle Aged; Ph | 1992 |
[Convulsive seizures under viloxazine therapy].
Topics: Depressive Disorder; Female; Humans; Middle Aged; Seizures; Viloxazine | 1991 |
Age, therapeutic "milieu" and clinical outcome in depressive patients treated with viloxazine: a study with plasma levels.
Topics: Adult; Age Factors; Aged; Ambulatory Care; Depressive Disorder; Female; Follow-Up Studies; Hospitali | 1986 |
[Comparative evaluation of the therapeutic efficacy of the antidepressants adepren, linamiphen and emovit].
Topics: Adjustment Disorders; Adolescent; Adult; Aminoquinolines; Antidepressive Agents; Bipolar Disorder; D | 1986 |
Carbamazepine-viloxazine interaction in patients with epilepsy.
Topics: Adult; Carbamazepine; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Epilepsy; F | 1986 |
[Treatment of depressive conditions with viloxazine by the general practitioner].
Topics: Adult; Aged; Depressive Disorder; Family Practice; Female; Humans; Male; Middle Aged; Morpholines; V | 1985 |
A clinical and pharmacological study of the antidepressant activity of viloxazine in adult and elderly patients.
Topics: Adult; Age Factors; Aged; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Mid | 1985 |